Table 2 Quantitative comparison of metabolites quantified from the aqueous phase of control and XL765-treated U87IDHmut cell extract that presented correlation coefficient |r| higher than 0.8 in the S-plot (Fig. 3C).

From: PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

Metabolite

Control group concentration (mean ± STD) [fmol/cell]

XL765 group concentration (mean ± STD) [fmol/cell]

p-value

Change under XL765 treatment [%]

Alanine

0.82 ± 0.34

0.06 ± 0.04

<0.001

−92.13

2HG

1.49 ± 0.30

0.31 ± 0.09

<0.001

−79.38

Glutamate

4.47 ± 0.90

1.79 ± 0.40

<0.001

−60.04

Glutamine

5.26 ± 2.40

1.02 ± 0.63

<0.001

−80.56

Glutathione

0.67 ± 0.22

0.48 ± 0.10

0.025

−29.02

Aspartate

13.93 ± 5.15

3.30 ± 0.48

<0.001

−76.3

Creatine

0.67 ± 0.32

0.16 ± 0.06

0.001

−75.63

Phosphocreatine

0.41 ± 0.24

0.16 ± 0.06

0.060

−60.58

Choline

0.03 ± 0.04

0.16 ± 0.11

0.006

600.78

Phosphocholine

2.20 ± 1.49

0.18 ± 0.13

0.008

−70.99

Glycerylphosphorylcholine

8.34 ± 2.27

0.64 ± 0.24

<0.001

−48.45

AXP

4.44 ± 1.21

4.30 ± 1.22

<0.001

−57.02

Phenylalanine

1.04 ± 0.38

0.64 ± 0.21

0.010

−38.29

Formate

1.09 ± 0.26

0.51 ± 0.17

<0.001

−52.91

NAD(P)H/+

0.52 ± 0.16

0.19 ± 0.03

<0.001

−64.77

NAD(P)+

0.24 ± 0.11

0.08 ± 0.03

0.001

−64.66

  1. Metabolites in bold mark metabolites that are common in the two cell lines.